Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Government regulatory policy towards the Biopharmaceutical sector: regulatory outlook on biosimilars in Egypt.
The thesis examines the government regulatory policy towards the pharmaceutical biotechnology sector (Biopharmaceutical), with focus on Similar Biotherapeutic Products (biosimilars). Biosimilars are highly similar but not identical molecules that claim to have similar quality, safety and efficacy o...
Saved in:
| Main Author: | |
|---|---|
| Format: | Thesis |
| Published: |
AUC Knowledge Fountain
2013
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Government regulatory policy towards the Biopharmaceutical sector: regulatory outlook on biosimilars in Egypt.
- Self-Medication and Pharmaceutical Dispensing in Egypt: Practices, Policies, and Regulatory Challenges
- The pharmaceutical supply of brand and generic medicines in different rural and urban areas of Egypt.
- An exploration of the influence of employee empowerment on organisational commitment in the pharmaceutical regulatory affairs environment
- Manipulation of macrophage phagocytosis - development of an endogenous delivery system
- Modelling the market outlook and policy alternatives for the Wheat Sector in South Africa
- Essays on telecommunications demand and regulatory policies